Aethlon Medical, Inc.
AEMD
$0.58
-$0.02-2.63%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -4.83% | 39.66% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.83% | 39.66% | |||
| Operating Income | 4.83% | -39.66% | |||
| Income Before Tax | 6.63% | -35.71% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 6.63% | -35.71% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 6.63% | -35.71% | |||
| EBIT | 4.83% | -39.66% | |||
| EBITDA | 4.92% | -41.80% | |||
| EPS Basic | 39.05% | 34.46% | |||
| Normalized Basic EPS | 37.98% | 32.96% | |||
| EPS Diluted | 39.05% | 34.46% | |||
| Normalized Diluted EPS | 37.98% | 32.96% | |||
| Average Basic Shares Outstanding | 53.19% | 107.07% | |||
| Average Diluted Shares Outstanding | 53.19% | 107.07% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||